Veterinary Medicine Market Trends and Insights By Animal Type (Domesticated and Companion), Product (Drugs and Vaccines), Route of Administration (Oral, Parental), Distribution Channel (Veterinary Hospitals & Clinics, Retail Stores, Online Pharmacies) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa), Competitive Market Growth, Size, Share and Forecast to 2027
New York, US, May 10, 2022 (GLOBE NEWSWIRE) -- Veterinary Medicine Market Overview:
According to a Comprehensive Research Report by Market Research Future (MRFR), “Veterinary Medicine Market Information by Route of Administration, Animal Type, Distribution Channel, Product, and Region - Forecast till 2027”, the market is anticipated to reach USD 42,985.42 Million at CAGR of approximately 5.57% during the review timeframe of 2020 to 2027. The report states that the market was valued at over USD 28,012.73 Million in the year 2019.
Like animals, animals are also vulnerable to various diseases. Veterinary medicine reduces the disease burden on pets and animals.
The global market for veterinary medicines has prominent players such as:
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/844
The global market for veterinary medicines has registered a major spike in the growth rate in the last few years. The market's growth is mainly credited to the growing number of pet ownership across the globe. Furthermore, the factors such as the increase in demand for livestock products, surge in the prevalence of various medical conditions in animals, the rise in livestock people, and increase in animal healthcare expenditure are also likely to boost the market's growth over the assessment timeframe.
On the other hand, the high costs of animal healthcare and the lack of veterinary infrastructure facilities across underdeveloped nations may impede the market's growth.
The global COVID-19 pandemic has affected a majority of the market sectors severely. The veterinary medicine market is no different than others. The global health crisis also had a massive impact on public health and animal health across the globe. The major global veterinary medicine market players take the tests on thousands of cats and dogs for the virus, which results in negative. In order to lower the risk of contamination and maintain hygiene, pet parents are prescribed to maintain distance from their pets. The global pandemic has had a major impact on the livestock sector that deals with issues of moving the animal products such as milk, meat, and eggs to market. At the pandemic's beginning, the FAO issued the latest livestock production and supply chain policy.
Browse In-depth Market Research Report (138 Pages) on Veterinary Medicine: https://www.marketresearchfuture.com/reports/veterinary-medicine-market-844
The global market for veterinary medicine has been segregated into various segments based on distribution channel, route of administration, product, animal type, and region.
Based on the animal type, the global market for veterinary medicine is split into companion and production. Among these two, the companion segment is likely to register the highest growth rate of over 6.04% over the assessment timeframe. The segment's growth is mainly attributed to the increasing adoption of pet animals across the globe. Furthermore, the increasing prevalence of chronic diseases among pets is another major aspect likely to boost the demand for veterinary medicine over the coming years. on the other hand, the production segment accounts for the highest revenue share of over 55.0% of the global revenue in 2020. The segment's brilliant performance is credited to the growing spending on animal health and the rising demand for proteins produced by animals.
The global veterinary medicine market is divided into medicinal, biological, and pharmaceuticals feed additives based on product. Out of all these, the pharmaceutical segment secured the leading position in the global market in 2020 with a share of over 57.0%. The segment's growth is mainly due to the growing prevalence of brucellosis, food-borne diseases, and zoonotic diseases.
Based on the route of administration, the global market for veterinary medicine is divided into parental, oral, and others. The parental segment is leading the global market with a contribution of over 44.0% in 2020. The segment's growth is mainly credited to the instant onset of action and availability of products. On the other hand, given the advances in oral veterinary medicines such as tablets, chewable, etc., the oral segment is likely to present the highest growth over the forecasted timeframe.
Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=844
The global market for veterinary medicines is divided into online pharmacies, retail stores, and hospitals & clinics based on distribution channels. The veterinary hospitals & clinics segment is projected to lead the global market with the highest contribution of over 72% in 2020. The segment's growth is accredited to the specialized surgeries, laser diagnostics, advanced diagnostic imaging, nuclear and regenerative medicines, and the novel therapies available in veterinary hospitals & clinics.
The global veterinary medicines market is studied across four major regions: the Middle East & Africa, Europe, the Americas, and Asia-Pacific.
As per the MRFR analysis, the North American region will likely secure the top position in the global veterinary medicines market over the assessment timeframe. The regional market's growth is mainly driven by the rising prevalence of animal diseases and increasing companion animal ownership. Furthermore, the growing population of pets and livestock coupled with a wide number of veterinary practices may propel the regional market's growth over the assessment era.
The veterinary medicines market for the European region is likely to grow substantially over the assessment timeframe. The regional market's growth is mainly driven by the increasing prevalence of diseases, the presence of developed veterinary healthcare infrastructure, and new product approvals.
Share your Queries @ https://www.marketresearchfuture.com/enquiry/844
The Asia-Pacific regional market for veterinary medicines is anticipated to secure the third position globally. The regional market's growth is driven by the factors such as government campaigns for the welfare of pet animals across developing countries, growing awareness regarding animal welfare, increasing the number of private veterinary clinics, and increasing penetration of the veterinary sector across the region.
Discover more research Reports on Healthcare Industry, by Market Research Future:
Spinal Implants Market Research Report: By Product (Spinal Fusion Devices, Non-Fusion Devices, Spinal Bone Stimulators), Procedure (Open Surgery, Minimally Invasive Surgery), Material (Titanium, Titanium-Alloy, Steel, Plastic) - Forecast To 2027
Clinical Trial Management System Market Research Report: By Type (Enterprise CTMS and On-Site CTMS), Delivery Model (Web-Based [Hosted CTMS], Licensed Enterprise, Cloud-Based CTMS [SaaS]), Component (Software, Service and Hardware), End-User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Contract Research Organizations and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027
Orthopedic Trauma Devices Market Size, Trends and Growth Analysis By Material Type (Bioabsorbable Materials, Non-Absorbable Materials), Product Type (Internal Fixator, External Fixator), End-User (Hospitals, Clinics, Orthopedic Centers)- Forecast Till 2027
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Stop investing in mediocre businesses. Buy the best, instead.
Fight back against inflation. This is how Dalio does it.
Real estate mogul Barbara Corcoran didn't mince words when asked about Tesla (TSLA) CEO Elon Musk's recent behavior.
The stock market pulled back from the brink of a bear market as rate-hike expectations eased, at least for now. Here's what it will take to signal a bottom.
(Bloomberg) -- The stock market has staged a ferocious rebound in the past week after almost falling into a bear market. Don’t get too excited about that, says Victoria Greene, founding partner and chief investment officer at G Squared Private Wealth.Most Read from BloombergElon Musk Says Bill Gates Has ‘Multi-Billion Dollar’ Tesla Short PositionElizabeth Holmes Urges Judge to Overturn Verdict and Acquit HerWalmart, Gap and Others Amass $45 Billion in Extra Stuff to SellRussian Wins in Eastern U
The stock market selloff has made many stocks look cheap—but smart investors need to be selective. Here are six high-quality companies that trade at reasonable valuations.
Giving too much money to these giants? Then start collecting rent from them.
Stocks have been inching back in recent days from the brink of bear market territory. It may be time to scoop up shares at steep discounts.
Here's what a fundamental and technical analysis says about Google stock. GOOGL stock buybacks remain high as web search and YouTube advertising rebound. But cloud computing growth is key.
‘Both are insistent that I'm taking money that is morally theirs. There's no changing their mind.’
The stock market ended its multiweek losing streak, and like a sports team that finally got a win, it’s worth celebrating. It just doesn’t mean the team—or this stock market—is any good. “Stocks finally enjoyed a strong bounce this week,” writes Canaccord Genuity analyst Martin Roberge.
The top-ranked companies on dividend payout ratios outperformed those stocks with less robust buyback activity—10.9% versus 9.3% on an annual basis over the 20-year period that concluded at the end of 2019.
When looking for the best artificial intelligence stocks to buy, identify companies using AI technology to improve products or gain a strategic edge, such as Google, Microsoft and Nvidia.
Investors finally got the week they had hoped to see, producing a sizable rebound from last week's stock market lows. There's still plenty of uncertainty in the economy, but investors are starting to think that the Federal Reserve might not be as aggressive as feared in fighting inflation. The Dow Jones Industrial Average (DJINDICES: ^DJI), S&P 500 (SNPINDEX: ^GSPC), and Nasdaq Composite (NASDAQINDEX: ^IXIC) were all up substantially on the week, including big gains on Friday.
Wood's flagship Ark Innovation ETF has fallen 52% this year as technology companies have tumbled.
The company does not have a long history of payouts, but it has the qualities of an excellent dividend stock.
Financial technology company Upstart Holdings (NASDAQ: UPST) has proven to be one of the most volatile stocks on Wall Street since going public at the end of 2020. Investors were shocked when Upstart's 2022 first-quarter earnings report revealed a surge in loans on the company's balance sheet, a potentially risky situation in an economy that appears to be slowing. Upstart receives a fee for the loans it touches, making it more a technology platform than an actual lender.
Here are May's best Chinese stocks to buy and watch as China starts to ease Covid lockdowns. Regulatory relief hopes also are rising.
If you have $77,280 that you can afford to invest, these stocks can turn that into $400 in recurring monthly income.
The S&P 500 is right on the cusp of entering a bear market, defined as a 20% decline from the recent peak. While bear markets can be brutal, they often provide the opportunity to buy high-quality companies at much more attractive valuations. With an eye toward opportunity, we asked some of our contributors what stocks are on their bear market watch list.